+221.4%
SPXL vs BBIO
+154.4%
+66.9%
-48.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | -0.1% | +2.5% | +2.5% |
| 7D | -2.5% | -3.2% | +0.7% | -1.6% |
| 30D | -4.2% | -13.6% | +9.4% | -0.1% |
| 3M | +8.1% | +7.2% | +0.9% | +5.0% |
| 6M | +35.6% | +1.5% | +34.1% | +33.7% |
| YTD | +28.8% | -5.3% | +34.1% | +28.3% |
| 1Y | +39.8% | +37.7% | +2.1% | +23.0% |
| 3Y | +221.4% | +153.9% | +67.5% | +118.4% |
| All | +221.4% | +154.4% | +66.9% | +118.4% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling